Skip to main content

Articles By Olga Petryna, MD

Pipeline

Emerging Therapies in Spondyloarthritis: A Promising Pipeline

By Olga Petryna, MD
24 November 2021

Growing awareness of spondyloarthropathies over the last two decades has led to a better understanding of the pathophysiology of spondyloarthritis, and subsequently increased interest in more distinct, disease state specific treatment options.

Read Article
Lab work

Infection or Disease Flare: What Tools Can Help Differentiate?

By Olga Petryna, MD
08 November 2021

Differentiation between a flare of disease and infection in patients with autoinflammatory (AI) conditions, where fever is the hallmark, can be extremely difficult. Few studies have evaluated potential differentiators; and having such tools would meet a huge unmet need. 

Read Article
Pipeline

Emerging Therapies in Spondyloarthritis: A Promising Pipeline

By Olga Petryna, MD
06 November 2021

Growing awareness of spondyloarthropathies over the last two decades has led to a better understanding of the pathophysiology of spondyloarthritis, and subsequently increased interest in more distinct, disease state specific treatment options.

Read Article
Liver.hepatitis.jpg

Liver Management in Rheumatoid Arthritis - RNL2021 Highlight

By Olga Petryna, MD
22 March 2021

While rheumatoid arthritis (RA) is not known to affect the liver directly, underlying liver disease and treatment-related effects on the liver can often become an obstacle in the management of many RA patients. In his Sunday presentation at RNL2021, Dr.

Read Article
gout.podagra.jpg

Pegloticase in Severe Refractory Gout

By Olga Petryna, MD
25 November 2020

Listen as Dr. Petryna reviews abstracts #0683 (Pharmacokinetics of Pegloticase and Methotrexate Polyglutamate(s) in Patients with Uncontrolled Gout Receiving Pegloticase and Co-treatment of Methotrexate) and #0677 (A Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled GOut Receiving Pegloticase (MIRROR): 12-Month Results of an Open-Label Study) from the 2020 ACR meeting. 

Read Article
key solution goal plan problem solve

Diagnostic tools in autoinflammatory syndromes

By Olga Petryna, MD
10 November 2020

With broader awareness about the disease state, early diagnosis and treatment in autoinflammatory syndromes, and its life threatening complication Macrophage Activation Syndrome, remains a huge unmet need.

Read Article
now later delay sign

Diagnostic Delay in Psoriatic Arthritis: What are the Consequences?

By Olga Petryna, MD
06 November 2020

Despite increased awareness and better diagnostic modalities at hand, early diagnosis of psoriatic arthritis (PsA) still remains a huge unmet need.

Read Article
psoriatic.PIP_.JPG

Are we doing our best treating seronegative arthritides?

By Olga Petryna, MD
09 June 2020

Every time a big scientific meeting ends I ask myself a question: how is it going to affect the way I treat my patients? This year the question pertains to management of axial spondyloarthropathies and psoriatic arthritis.

Read Article
foot%20pain.jpg

Pegradicase+ImmTOR SEL-212 Shows Promising Results In Active Gout

By Olga Petryna, MD
25 November 2019

Therapies targeting sUA accumulation or improving its excretion are widely used for treatment of symptoms and prevention of progression of gout for decades.

Read Article
gout.MTP_.jpg

PANLAR Ultrasound Study Group: Recommendations On Imaging Modalities In Gout

By Olga Petryna, MD
20 November 2019

Gout is a systemic inflammatory disease with high potential for joint damage due to erosive changes and MSU deposits resulting in disability and chronic pain. Prompt diagnosis and effective treatment are key to better long term outcomes and decreased disability.

Read Article
×